Millions of people in developing countries rely on affordable generic medicines to stay alive. More than 80 per cent of the medicines used by Médecins Sans Frontières (MSF) to treat AIDS across the developing world are produced in India. But the European Commission is now shutting off the tap of affordable medicines by attacking the production, registration, transportation and exportation of generic medicines. Visit this page of you're interested in helping Médecins Sans Frontières send a message to the European Commission to keep their hands of our medicine.